Skip to content

Orcetidine was used in clinical study of patients with ARDS

Orcetidine was used in clinical study of patients with ARDS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099419
Enrollment
Unknown
Registered
2025-03-24
Start date
2024-11-10
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome

Interventions

Control Group:Morphine was given 1.0~2.5mg/h to maintain a CPOT score of <3
Observation group:Ocelidine 2-20 µg/kg/h was given and the CPOT score was maintained <3 points

Sponsors

Shandong Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years and 72h; 4.No allergic reaction to the drugs used in this study; 5.The informed consent form shall be signed by the patient and his family.

Exclusion criteria

Exclusion criteria: 1.Expected survival time < 14 days; 2.Pregnancy or lactation; 3.Patients with myasthenia gravis, acute myocardial ischemia, or severe arrhythmias; 4.Severe head injury, brain tumor, coma, status epilepticus, etc; 5.Patients with a history of alcohol or drug abuse or chronic pain requiring long-term use of analgesic and sedative drugs; 6.Any condition that impedes the proper assessment of cognitive function, such as language and sensory disorders or mental disorders (language difficulties or sexual dysfunction); 7.Participate in other exploratory clinical trials within 3 months before screening; 8.With malignant lesions; 9.Liver, kidney and other organ function failure.

Design outcomes

Primary

MeasureTime frame
Analgesic effect;

Secondary

MeasureTime frame
Clinical indicators;Hemodynamics;Adverse reactions;

Countries

China

Contacts

Public ContactDai Jingcun

Shandong Rehabilitation Hospital

daijcandclf1@163.com+86 531 81210591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026